NVP-ABE854

NVP-ABE854 is a synthetic small molecule belonging to the class of 6-amino purines. It features a cyclohexylamino group at position 6 and a substituted piperazine ethyl chain at position 9 on the purine core. This compound has been studied as an inhibitor of cathepsin proteases, particularly Cathepsin K and Cathepsin S, which are cysteine proteases involved in bone resorption and immune system function, respectively. The molecule was developed as a lead structure for research into selective cathepsin inhibition, with potential applications in diseases such as osteoporosis or autoimmune disorders where these enzymes play key roles[2][6][10]. There is no evidence that it has advanced to clinical development or received regulatory approval.

Other names

6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile6-(Cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)ethyl]-9H-purine-2-carbonitrile6-(cyclohexylamino)-9-[2-(4-methylpiperazinyl)ethyl]purine-2-carbonitrile